AI News

    OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

    Lightspeed is in discussions to lead the funding round, sources say.

    Read the full story at TechCrunch AI
    TA

    TechCrunch AI

    Source

    TechCrunch AI
    OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
    AI Analysis

    Generated insight by OnAirToday AI

    The convergence of AI and drug discovery is accelerating, with established AI researchers like Miles Wang actively building dedicated startups. This signals a significant shift towards AI-driven pharmaceutical innovation with substantial early-stage investment potential.

    Powered by AI • Not a substitute for human analysisMore Insights →
    Read the full story at TechCrunch AI →
    Share
    Filed under:AI News

    Comments

    Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.

    0/1000